The relationship between metabolic hormone levels and the prevalence of hypertension in people under 45 years of age
Open Access
- 21 January 2025
- journal article
- Published by Arterialnaya Gipertenziya in "Arterial’naya Gipertenziya" ("Arterial Hypertension")
- Vol. 30 (5) , 477-486
Abstract
Among the various factors potentially involved in the pathogenesis of cardiovascular diseases, arterial hypertension (HTN), in the structure of which the proportion of young people increases, is still the most common risk factor for the development of serious cardiovascular complications. The development of structural and functional disorders associated with HTN is accompanied by an increase or decrease in markers of metabolic disorders. Objective. Тo study the prevalence of HTN in young people of working age and childbearing age, depending on the levels of metabolic hormones. Design and methods. The study included 1,340 people from the Novosibirsk population sample aged 25–44 years. HTN was diagnosed in case of the average systolic blood pressure ≥ 140 mmHg and/or diastolic blood pressure ≥ 90 mmHg. The levels of amylin, C-peptide, ghrelin, glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide 1 (GLP-1), glucagon, insulin, pancreatic polypeptide (PP), and peptide YY (PYY) were determined by multiplex analysis. Results. In the quartile with the highest values of amylin, C-peptide, GIP, GLP-1 and PP, the prevalence of HTN is significantly higher compared to Q1. In the group of HTN patients, the levels of amylin, C-peptide, ghrelin, GIP, GLP-1, insulin and PP were 2,4 (p < 0,0001), 1,4 (p < 0,0001), 1,3 (p = 0,001), 1,3 (p = 0,003), 1,6 (p = 0,001), 1,2 (p = 0,002) and 1,4 (p = 0,006) times higher, respectively, in comparison with persons without HTN. Conclusions. The prevalence of HTN is associated with high values of amylin, ghrelin, glucagon, insulin and C-peptide. The chance of HTN increases starting from the second quartile of amylin and increases with each quartile.Keywords
This publication has 23 references indexed in Scilit:
- Biochemical markers of hypertension, prehypertensionAnnales de Cardiologie et d'Angéiologie, 2018
- Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular MechanismsCanadian Journal of Cardiology, 2018
- Fasting insulin, insulin resistance and risk of hypertension in the general population: A meta-analysisClinica Chimica Acta, 2017
- Amylin deposition in the kidney of patients with diabetic nephropathyKidney International, 2007
- Role of islet amyloid in type 2 diabetes mellitusThe International Journal of Biochemistry & Cell Biology, 2006
- Growth hormone releasing peptide (ghrelin) is synthesized and secreted by cardiomyocytesCardiovascular Research, 2004
- Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studiesThe Lancet, 2002
- Insulin signalling and the regulation of glucose and lipid metabolismNature, 2001
- Amylin: History and OverviewDiabetic Medicine, 1997
- Rat amylin mediates a pressor response in the anaesthetised rat: implications for the association between hypertension and diabetes mellitusDiabetologia, 1997